1. Home
  2. ALCO vs XBIT Comparison

ALCO vs XBIT Comparison

Compare ALCO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$40.73

Market Cap

297.9M

Sector

N/A

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.39

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
XBIT
Founded
1960
2005
Country
United States
United States
Employees
172
85
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.9M
73.2M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ALCO
XBIT
Price
$40.73
$2.39
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$44.00
N/A
AVG Volume (30 Days)
14.3K
20.8K
Earning Date
05-11-2026
05-08-2026
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
1.03
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$39.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.89
$2.09
52 Week High
$45.01
$3.61

Technical Indicators

Market Signals
Indicator
ALCO
XBIT
Relative Strength Index (RSI) 47.43 40.97
Support Level $39.98 $2.35
Resistance Level $42.55 $2.41
Average True Range (ATR) 1.07 0.06
MACD -0.08 -0.02
Stochastic Oscillator 38.00 21.74

Price Performance

Historical Comparison
ALCO
XBIT

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: